Annual EBITDA
$4.31 B
+$5.49 B+465.89%
March 31, 2024
Summary
- As of February 12, 2025, ROIV annual EBITDA is $4.31 billion, with the most recent change of +$5.49 billion (+465.89%) on March 31, 2024.
- During the last 3 years, ROIV annual EBITDA has risen by +$5.21 billion (+581.19%).
- ROIV annual EBITDA is now at all-time high.
Performance
ROIV EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$336.87 M
-$425.30 M-480.96%
September 30, 2024
Summary
- As of February 12, 2025, ROIV quarterly EBITDA is -$336.87 million, with the most recent change of -$425.30 million (-480.96%) on September 30, 2024.
- Over the past year, ROIV quarterly EBITDA has dropped by -$157.82 million (-88.14%).
- ROIV quarterly EBITDA is now -106.59% below its all-time high of $5.11 billion, reached on December 31, 2023.
Performance
ROIV Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$4.69 B
-$142.52 M-2.95%
September 30, 2024
Summary
- As of February 12, 2025, ROIV TTM EBITDA is $4.69 billion, with the most recent change of -$142.52 million (-2.95%) on September 30, 2024.
- Over the past year, ROIV TTM EBITDA has increased by +$257.25 million (+5.81%).
- ROIV TTM EBITDA is now -2.95% below its all-time high of $4.83 billion, reached on June 30, 2024.
Performance
ROIV TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ROIV EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +465.9% | -88.1% | +5.8% |
| 3 y3 years | +581.2% | -16.9% | +612.9% |
| 5 y5 years | +581.2% | -16.9% | +612.9% |
ROIV EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +465.9% | -106.6% | +8.6% | -3.0% | +460.0% |
| 5 y | 5-year | at high | +465.9% | -106.6% | +8.6% | -3.0% | +460.0% |
| alltime | all time | at high | +465.9% | -106.6% | +8.6% | -3.0% | +460.0% |
Roivant Sciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$336.87 M(-481.0%) | $4.69 B(-3.0%) |
| Jun 2024 | - | $88.43 M(-149.4%) | $4.83 B(+9.0%) |
| Mar 2024 | $4.31 B(-465.9%) | -$179.05 M(-103.5%) | $4.43 B(-0.3%) |
| Dec 2023 | - | $5.11 B(-2730.9%) | $4.44 B(-527.7%) |
| Sep 2023 | - | -$194.35 M(-37.6%) | -$1.04 B(-9.3%) |
| Jun 2023 | - | -$311.34 M(+89.0%) | -$1.14 B(-2.8%) |
| Mar 2023 | -$1.18 B | -$164.69 M(-55.3%) | -$1.18 B(-9.5%) |
| Dec 2022 | - | -$368.48 M(+22.7%) | -$1.30 B(+5.3%) |
| Sep 2022 | - | -$300.35 M(-12.8%) | -$1.24 B(+6.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$344.50 M(+19.5%) | -$1.16 B(+26.9%) |
| Mar 2022 | -$910.77 M(+1.7%) | -$288.30 M(-4.9%) | -$913.63 M(-7.8%) |
| Dec 2021 | - | -$303.18 M(+35.5%) | -$991.01 M(+4.7%) |
| Sep 2021 | - | -$223.69 M(+127.2%) | -$946.90 M(+7.6%) |
| Jun 2021 | - | -$98.47 M(-73.1%) | -$879.76 M(-1.8%) |
| Mar 2021 | -$895.74 M | -$365.67 M(+41.1%) | -$895.74 M(+69.0%) |
| Dec 2020 | - | -$259.07 M(+65.5%) | -$530.06 M(+95.6%) |
| Sep 2020 | - | -$156.54 M(+36.8%) | -$270.99 M(+136.8%) |
| Jun 2020 | - | -$114.45 M | -$114.45 M |
FAQ
- What is Roivant Sciences annual EBITDA?
- What is the all time high annual EBITDA for Roivant Sciences?
- What is Roivant Sciences annual EBITDA year-on-year change?
- What is Roivant Sciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Roivant Sciences?
- What is Roivant Sciences quarterly EBITDA year-on-year change?
- What is Roivant Sciences TTM EBITDA?
- What is the all time high TTM EBITDA for Roivant Sciences?
- What is Roivant Sciences TTM EBITDA year-on-year change?
What is Roivant Sciences annual EBITDA?
The current annual EBITDA of ROIV is $4.31 B
What is the all time high annual EBITDA for Roivant Sciences?
Roivant Sciences all-time high annual EBITDA is $4.31 B
What is Roivant Sciences annual EBITDA year-on-year change?
Over the past year, ROIV annual EBITDA has changed by +$5.49 B (+465.89%)
What is Roivant Sciences quarterly EBITDA?
The current quarterly EBITDA of ROIV is -$336.87 M
What is the all time high quarterly EBITDA for Roivant Sciences?
Roivant Sciences all-time high quarterly EBITDA is $5.11 B
What is Roivant Sciences quarterly EBITDA year-on-year change?
Over the past year, ROIV quarterly EBITDA has changed by -$157.82 M (-88.14%)
What is Roivant Sciences TTM EBITDA?
The current TTM EBITDA of ROIV is $4.69 B
What is the all time high TTM EBITDA for Roivant Sciences?
Roivant Sciences all-time high TTM EBITDA is $4.83 B
What is Roivant Sciences TTM EBITDA year-on-year change?
Over the past year, ROIV TTM EBITDA has changed by +$257.25 M (+5.81%)